UNSPSC 85813013: Introduction of monoclonal antibody into genitourinary tract, percutaneous approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of monoclonal antibody into genitourinary tract, percutaneous approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E0K30M

UNSPSC 85813013, Introduction of monoclonal antibody into genitourinary tract, percutaneous approach, is a Commodity code that shows minimal alignment between the code's nominal scope and recent state and local procurement activity. The recent opportunities block contains no solicitations matching the code's clinical specificity; instead, the tagged opportunities span virtual urgent care, general medical services, PACE operations, occupational health, cancer screening, wellness programs, and opioid treatment — none involving monoclonal antibody administration or genitourinary interventions. State and local procurement systems occasionally tag opportunities with codes that do not reflect the actual work being bought, and this code appears to exemplify that mismatch. The code sees no relevant recent activity among the opportunities posted across California, Colorado, Georgia, Nevada, New Jersey, Kansas, Texas, Missouri, Florida, Illinois, Oregon, and Washington.

No representative recent opportunities tied to this code's stated scope are present in the source material. The procurement activity visible under this code number does not support a meaningful pursuit decision for vendors specializing in monoclonal antibody therapeutics or urologic interventions. Business development teams should verify code assignment with issuing bodies before investing pursuit resources.